Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins - PubMed (original) (raw)

Clinical Trial

Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins

T J Mühlebach et al. Clin Exp Immunol. 1992 May.

Abstract

Recombinant interferon-gamma (rIFN-gamma) has been described to enhance phagocyte functions in vitro and in vivo in several patients with chronic granulomatous disease (CGD). To demonstrate the clinical usefulness of this treatment, 128 patients were treated in a randomized, double-blind multi-centre study with a placebo preparation or with rIFN-gamma. We analysed parameters of neutrophil oxidative and non-oxidative metabolism in 16 patients enrolled in this study. No enhanced superoxide-release was observed in patients treated with rIFN-gamma compared to placebo-treated patients. Phagocyte cytochrome b558 content also remained unchanged. Levels of four non-oxidative antimicrobial proteins (cathepsin G, azurocidine, p29b, lactoferrin) rose, fell, or remained unchanged, irrespective of treatment with rIFN-gamma or placebo.

PubMed Disclaimer

Similar articles

• Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
  Woodman RC, Erickson RW, Rae J, Jaffe HS, Curnutte JT. Woodman RC, et al. Blood. 1992 Mar 15;79(6):1558-62. Blood. 1992. PMID: 1312372
• In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
  Rex JH, Bennett JE, Gallin JI, Malech HL, DeCarlo ES, Melnick DA. Rex JH, et al. J Infect Dis. 1991 Apr;163(4):849-52. doi: 10.1093/infdis/163.4.849. J Infect Dis. 1991. PMID: 1901332 Clinical Trial.
• Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.
  Bemiller LS, Roberts DH, Starko KM, Curnutte JT. Bemiller LS, et al. Blood Cells Mol Dis. 1995;21(3):239-47. doi: 10.1006/bcmd.1995.0028. Blood Cells Mol Dis. 1995. PMID: 8673477 Clinical Trial.
• Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood.
  Gallin JI. Gallin JI. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 2):S100-5. doi: 10.1016/s0090-1229(05)80044-3. Clin Immunol Immunopathol. 1991. PMID: 1934607 Review.
• Chronic granulomatous disease.
  Dinauer MC, Orkin SH. Dinauer MC, et al. Annu Rev Med. 1992;43:117-24. doi: 10.1146/annurev.me.43.020192.001001. Annu Rev Med. 1992. PMID: 1316094 Review.

Cited by

• The molecular basis of chronic granulomatous disease.
  Meischl C, Roos D. Meischl C, et al. Springer Semin Immunopathol. 1998;19(4):417-34. doi: 10.1007/BF00792600. Springer Semin Immunopathol. 1998. PMID: 9618766 Review.
• Use of cytokine therapy in primary immunodeficiency.
  Roy-Ghanta S, Orange JS. Roy-Ghanta S, et al. Clin Rev Allergy Immunol. 2010 Feb;38(1):39-53. doi: 10.1007/s12016-009-8131-4. Clin Rev Allergy Immunol. 2010. PMID: 19449141 Review.
• Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.
  Ahlin A, Lärfars G, Elinder G, Palmblad J, Gyllenhammar H. Ahlin A, et al. Clin Diagn Lab Immunol. 1999 May;6(3):420-4. doi: 10.1128/CDLI.6.3.420-424.1999. Clin Diagn Lab Immunol. 1999. PMID: 10225847 Free PMC article.
• Beyond oxidative stress: an immunologist's guide to reactive oxygen species.
  Nathan C, Cunningham-Bussel A. Nathan C, et al. Nat Rev Immunol. 2013 May;13(5):349-61. doi: 10.1038/nri3423. Nat Rev Immunol. 2013. PMID: 23618831 Free PMC article. Review.
• Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease.
  Hague RA, Eastham EJ, Lee RE, Cant AJ. Hague RA, et al. Arch Dis Child. 1993 Oct;69(4):443-5. doi: 10.1136/adc.69.4.443. Arch Dis Child. 1993. PMID: 8259876 Free PMC article.

References

1. 1. Interferon. 1986;7:125-43 - PubMed
2. 1. J Clin Invest. 1987 Oct;80(4):1009-16 - PubMed
3. 1. Adv Hum Genet. 1987;16:229-97 - PubMed
4. 1. Hematol Oncol Clin North Am. 1988 Jun;2(2):267-76 - PubMed
5. 1. J Clin Immunol. 1988 Nov;8(6):419-25 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems
  • Wiley